Market closed
TriSalus Life Sciences, Inc./$TLSI
13:30
21:10
04:45
12:25
20:00
1D1W1MYTD1Y5YMAX
About TriSalus Life Sciences, Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
Ticker
$TLSI
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
110
Website
TLSI Metrics
BasicAdvanced
$185M
-
-$1.31
0.49
-
Price and volume
Market cap
$185M
Beta
0.49
52-week high
$5.83
52-week low
$4.60
Average daily volume
61K
Financial strength
Current ratio
2.021
Quick ratio
1.331
Long term debt to equity
-90.419
Total debt to equity
-91.253
Interest coverage (TTM)
-11.70%
Management effectiveness
Return on assets (TTM)
-90.97%
Return on equity (TTM)
115.93%
Valuation
Price to revenue (TTM)
4.932
Price to book
-6.92
Price to tangible book (TTM)
-6.92
Price to free cash flow (TTM)
-3.524
Growth
Revenue change (TTM)
58.99%
Earnings per share change (TTM)
-80.52%
3-year revenue growth (CAGR)
51.88%
3-year earnings per share growth (CAGR)
-26.13%
TLSI News
AllArticlesVideos
TriSalus Life Sciences: Optimistic Guidance For 2025, But There Are Still Risks
Seeking Alpha·4 weeks ago
TriSalus Life Sciences, Inc. (TLSI) Q4 2024 Earnings Call Transcript
Seeking Alpha·1 month ago
TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial Results and Provides Business Update
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for TriSalus Life Sciences, Inc. stock?
TriSalus Life Sciences, Inc. (TLSI) has a market cap of $185M as of April 28, 2025.
What is the P/E ratio for TriSalus Life Sciences, Inc. stock?
The price to earnings (P/E) ratio for TriSalus Life Sciences, Inc. (TLSI) stock is 0 as of April 28, 2025.
Does TriSalus Life Sciences, Inc. stock pay dividends?
No, TriSalus Life Sciences, Inc. (TLSI) stock does not pay dividends to its shareholders as of April 28, 2025.
When is the next TriSalus Life Sciences, Inc. dividend payment date?
TriSalus Life Sciences, Inc. (TLSI) stock does not pay dividends to its shareholders.
What is the beta indicator for TriSalus Life Sciences, Inc.?
TriSalus Life Sciences, Inc. (TLSI) has a beta rating of 0.49. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.